Erik Henau, PLC’s () chief executive, believes a more measured approach to its entry into the Chinese market will make progress smoother in future.
Henau says it is been a steep learning curve in China, but the company has made major strides forward.
More staff have been appointed in the country, while new operating procedures have led to ‘huge improvements’ in manufacturing and logistics.
In Europe, the CE process for its urine-based fertility test is progressing and has started to gently market its MyLotus product in the UK in anticipation of approval in the summer.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Concepta named herein, including the promotion by the Company of Concepta in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HERE